UNSPSC 51342702: Enfuvirtide

This classification denotes an anti-hiv agent with the molecular formula C204H301N51O64, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 19OWO1T3ZE, chemically known as l-phenylalaninamide, n-acetyl-l-tyrosyl-l-threonyl-l-seryl-l-leucyl-l-isoleucyl-l-histidyl-l-seryl-l-leucyl-l-isoleucyl-l-alpha-glutamyl-l-alpha-glutamyl-l-seryl-l-glutaminyl-l-asparaginyl-l-glutaminyl-l-glutaminyl-l-alpha-glutamyl-l-lysyl-l-asparaginyl-l-alpha-glutamyl-l-glutaminyl-l-alpha-glutamyl-l-leucyl-l-leucyl-l-alpha-glutamyl-l-leucyl-l-alpha-aspartyl-l-lysyl-l-tryptophyl-l-alanyl-l-seryl-l-leucyl-l-tryptophyl-l-asparaginyl-l-tryptophyl- but generally known as enfuvirtide, which bears US NIH Compound Identifier 16130199.

UNSPSC 51342702 Enfuvirtide is a Commodity code for a specific antiviral pharmaceutical product, but the recent state and local opportunities posted under this code do not align with enfuvirtide procurement. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through MMCAP Infuse to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride — antibiotics, not antivirals — while Seminole County, Florida issued an IFB for Naloxone and Safe Drug Deactivation Systems, neither of which falls within the enfuvirtide scope. State and local procurement systems occasionally mislabel opportunities at the commodity tier when routing through cooperative purchasing vehicles or when catalog codes are applied incorrectly during data entry. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.

The Illinois contract, awarded August 28, 2026 for $2,999,999.11 over 12 months with two renewal years, demonstrates the scale of state pharmaceutical procurement through consortium vehicles like MMCAP Infuse, but the products supplied do not match the enfuvirtide classification. The Seminole County opportunity, posted June 30, 2026 with a response deadline of July 26, 2023 (a date inconsistency suggesting data corruption in the source), was likewise misclassified. No open enfuvirtide solicitations appear in the recent activity block. Business development professionals should verify code assignment directly with issuing agencies before pursuing opportunities initially tagged under this commodity code.